2 options
Improving Regulatory Transparency for New Medical Therapies Act : report (to accompany H.R. 4299) (including cost estimate of the Congressional Budget Office).
- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on Energy and Commerce, author.
- United States. Congress. House. Committee on the Judiciary, author.
- Series:
- United States. Congress. House. Report ; 113-565.
- Report / 113th Congress, 2d session, House of Representatives ; 113-565
- Language:
- English
- Subjects (All):
- Drugs of abuse--Law and legislation--United States.
- Drugs of abuse.
- Drug approval--United States.
- Drug approval.
- Drugs of abuse--Law and legislation.
- United States.
- Genre:
- legislative records.
- Legislative materials.
- Physical Description:
- 1 online resource (volumes).
- Place of Publication:
- [Washington, D.C.] : [U.S. Government Printing Office], [2014]-
- Notes:
- Title from pt. 1 title screen (viewed on Aug. 4, 2014).
- Title from pt. 2 title screen (viewed on Oct. 8, 2014).
- "Committee on the Judiciary"--Pt. 2.
- "July 29, 2014"--Pt. 1.
- "September 19, 2014"--Pt. 2.
- Other Format:
- Print version: United States. Congress. House. Committee on Energy and Commerce. Improving Regulatory Transparency for New Medical Therapies Act
- Microfiche version: United States. Congress. House. Committee on Energy and Commerce. Improving Regulatory Transparency for New Medical Therapies Act
- Online version: United States. Congress. House. Committee on Energy and Commerce. Improving Regulatory Transparency for New Medical Therapies Act
- OCLC:
- 885196378
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.